Immunization with different formulations of Mycobacterium tuberculosis antigen 85A induces immune responses with different specificity and protective efficacy

Immunization with different formulations of Mycobacterium tuberculosis antigen 85A induces immune responses with different specificity and protective efficacy

Pokaži ostale verzije (2)

To test the relative efficacy of CD4 and CD8T cells in mediating protective immunity to Mycobacterium tuberculosis (Mtb), we compared three immunization regimes designed to induce preferentially each subset. BALB/c mice were immunized intranasally (i.n.) or parenterally with antigen 85A either in a...

Bibliografski detalji
Glavni autori:	Tchilian, E, Ahuja, D, Hey, A, Jiang, S, Beverley, P
Format:	Journal article
Jezik:	English
Izdano:	2013

Slični predmeti

Immunization with different formulations of Mycobacterium tuberculosis antigen 85A induces immune responses with different specificity and protective efficacy.
od: Tchilian, E, i dr.
Izdano: (2013)

Immunization with different formulations of Mycobacterium tuberculosis antigen 85A induces immune responses with different specificity and protective efficacy
od: Tchilian, E, i dr.
Izdano: (2013)

Environmental effects on protection against Mycobacterium tuberculosis after immunization with Ad85A.
od: Beverley, P, i dr.
Izdano: (2013)

CXCR6 is a marker for protective antigen-specific cells in the lungs after intranasal immunization against Mycobacterium tuberculosis.
od: Lee, L, i dr.
Izdano: (2011)

CXCR6 Is a Marker for Protective Antigen-Specific Cells in the Lungs after Intranasal Immunization against Mycobacterium tuberculosis
od: Lee, L, i dr.
Izdano: (2011)

Heterologous priming-boosting immunization of cattle with Mycobacterium tuberculosis 85A induces antigen-specific T-cell responses.
od: Taracha, E, i dr.
Izdano: (2003)

Purification of Antigen 85 Complex of Mycobacterium tuberculosis
od: Uma Ranganathan, i dr.
Izdano: (2013-02-01)

Immunization of mice with a recombinant adenovirus vaccine inhibits the early growth of Mycobacterium tuberculosis after infection.
od: Ronan, E, i dr.
Izdano: (2009)

Immunization of Mice with a Recombinant Adenovirus Vaccine Inhibits the Early Growth of Mycobacterium tuberculosis After Infection
od: Ronan, E, i dr.
Izdano: (2009)

Chemokine gene expression in lung CD8 T cells correlates with protective immunity in mice immunized intra-nasally with Adenovirus-85A.
od: Lee, L, i dr.
Izdano: (2010)

Immunogenicity and protective efficacy of prime-boost regimens with recombinant (delta)ureC hly+ Mycobacterium bovis BCG and modified vaccinia virus ankara expressing M. tuberculosis antigen 85A against murine tuberculosis.
od: Tchilian, E, i dr.
Izdano: (2009)

Erratum: Immunogenicity and protective efficacy of prime-boost regimens with recombinant δureC hly+ Mycobacterium bovis BCG and modified Vaccinia virus Ankara expressing M. tuberculosis antigen 85A against murine tuberculosis
od: Tchilian, E, i dr.
Izdano: (2011)

Immunization With Mycobacterium tuberculosis Antigens Encapsulated in Phosphatidylserine Liposomes Improves Protection Afforded by BCG
od: Gil R. Diogo, i dr.
Izdano: (2019-06-01)

Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A.
od: Mcshane, H, i dr.
Izdano: (2002)

Immunization of mice with a recombinant adenovirus vaccine inhibits the early growth of Mycobacterium tuberculosis after infection.
od: Edward O Ronan, i dr.
Izdano: (2009-12-01)

A novel murine cytomegalovirus vaccine vector protects against Mycobacterium tuberculosis.
od: Beverley, P, i dr.
Izdano: (2014)

Protection Induced by Simultaneous Subcutaneous and Endobronchial Vaccination with BCG/BCG and BCG/Adenovirus Expressing Antigen 85A against Mycobacterium bovis in Cattle.
od: Gillian S Dean, i dr.
Izdano: (2015-01-01)

Incorporation of trehalose analogues into Mycobacterium Tuberculosis: antigen 85 and probes of bacterial infection
od: Backus, K
Izdano: (2011)

Harnessing local and systemic immunity for vaccines against tuberculosis.
od: Beverley, P, i dr.
Izdano: (2014)

Immunogenicity and Protective Efficacy of Prime-Boost Regimens with Recombinant Delta ureC hly(+) Mycobacterium bovis BCG and Modified Vaccinia Virus Ankara Expressing M. tuberculosis Antigen 85A against Murine Tuberculosis, (vol 77, pg 630, 2009)
od: Tchilian, E, i dr.
Izdano: (2011)

Immunity to Mycobacterium tuberculosis
od: James A. Triccas, i dr.
Izdano: (2011-01-01)

Human T Cell and Antibody-Mediated Responses to the Mycobacterium tuberculosis Recombinant 85A, 85B, and ESAT-6 Antigens
od: Gilson C. Macedo, i dr.
Izdano: (2011-01-01)

Cloning and Production of Antigen 85A Mycobacterium tuberculosis for Diagnostic Latent Tuberculosis: a Preliminary Study
od: Rosana Agus, i dr.
Izdano: (2023-12-01)

Understanding vaccine induced protective immunity to Mycobacterium tuberculosis
od: Ronan, E
Izdano: (2011)

Immune mechanisms of protection against Mycobacterium tuberculosis‐centers
od: Que Dang, i dr.
Izdano: (2024-10-01)

Evaluation of Humoral Immunity to Mycobacterium tuberculosis-Specific Antigens for Correlation with Clinical Status and Effective Vaccine Development
od: Mamiko Niki, i dr.
Izdano: (2015-01-01)

Chimeric antigen carried by extracellular vesicles induces stronger protective immunity against Mycobacterium tuberculosis infection
od: Lin Ji, i dr.
Izdano: (2024-09-01)

Simultaneous immunization against tuberculosis.
od: Tchilian, E, i dr.
Izdano: (2011)

Simultaneous immunization against tuberculosis.
od: Tchilian, E, i dr.
Izdano: (2011)

Differential and site specific impact of B cells in the protective immune response to Mycobacterium tuberculosis in the mouse.
od: Egídio Torrado, i dr.
Izdano: (2013-01-01)

HLA-B*35-restricted CD8 T cell epitopes in the antigen 85 complex of Mycobacterium tuberculosis.
od: Klein, MR, i dr.
Izdano: (2001)

Nasal associated lymphoid tissue (NALT) contributes little to protection against aerosol challenge with Mycobacterium tuberculosis after immunisation with a recombinant adenoviral vaccine.
od: Ronan, E, i dr.
Izdano: (2010)

Nasal associated lymphoid tissue (NALT) contributes little to protection against aerosol challenge with Mycobacterium tuberculosis after immunisation with a recombinant adenoviral vaccine.
od: Ronan, E, i dr.
Izdano: (2010)

Helminth Antigen Exposure Enhances Early Immune Control of Mycobacterium tuberculosis in Monocytes and Macrophages
od: Shambhuprasad Kotresh Togarsimalemath, i dr.
Izdano: (2020-12-01)

Heterologous prime-boost BCG with DNA vaccine expressing fusion antigens Rv2299c and Ag85A improves protective efficacy against Mycobacterium tuberculosis in mice
od: Juan Wu, i dr.
Izdano: (2022-10-01)

Innate Immune Recognition of Mycobacterium tuberculosis
od: Johanneke Kleinnijenhuis, i dr.
Izdano: (2011-01-01)

Inflammasomes in Mycobacterium tuberculosis-Driven Immunity
od: Sebastian Wawrocki, i dr.
Izdano: (2017-01-01)

Immunogenicity of recombinant mycobacterium smegmatis expressing antigen 85b epitopes as a potential tuberculosis vaccine candidate
od: Kadir , Nur Ayuni
Izdano: (2017)

Cloning, expression and purification of Ag85A-ESAT6 antigens of Mycobacterium tuberculosis as a fusion protein
od: M Shakouri, i dr.
Izdano: (2015-01-01)

Nano-Sized Chimeric Human Papillomavirus-16 L1 Virus-like Particles Displaying <i>Mycobacterium tuberculosis</i> Antigen Ag85B Enhance Ag85B-Specific Immune Responses in Female C57BL/c Mice
od: Fangbin Zhou, i dr.
Izdano: (2023-10-01)